Geriatric physical fitness Not Applicable
Conditions
Interventions
Current intervention as of 23/12/2019:
34 participants are blinded and randomly distributed in the experimental group called voluntary exercise with WB-EMS (EX + WB-EMS, n = 17) or the
Sponsors
Universitat de Lleida
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Sedentary 2. Aged over 55 years 3. Postmenopausal
Exclusion criteria
Exclusion criteria: Suffering from heart disease, metabolic disorders, tumors, or neurological disturbances
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 23/12/2019: Evaluation of physical fitness is carried out by the EXERNET test consisting of 8 tests modified and previously adapted from the Senior Fitness Test Battery and Eurofit Testing Battery, plus the progressive resistance test (PRT). Participants are evaluated at the beginning (baseline), at the end of the 10 weeks of intervention (post-intervention) and 6 months after the end of the intervention (follow-up). 1. Balance assessed using the flamingo test. The participant starts standing, with both feet on the ground. After the signal, she tries to stand on the sole of one foot. The time the subject is able to stay in that posture up to a maximum of 60 s is recorded. The test is performed alternately, twice with each leg and the best attempt of the four is counted. 2. Leg strength assessed using the chair stand test. The participant starts from a sitting position with her arms crossed and the palms of his hands resting on her shoulders. The number of times she is able to get up and sit in 30 s is counted. The test is performed only once. 3. Arm strength assessed using the arm curl test. The participant sits on a bench holding a 2.5-kg weight. The maximum number of elbow flexions and extensions that the participant is able to execute in 30 s is measured. The test is performed once with each arm. 4. Leg flexibility assessed using the chair sit-and-reach test. The participant begins the test sitting, with one leg extended and the heel resting on the floor, while her hands are directed towards the toes of that leg. The existing distance, positive or negative, in cm, between the fingers and toes is measured. The test is performed once with each leg. 5. Arm flexibility assessed using the back scratch test. The participant places one hand over the shoulder of that same arm, and the opposite hand from the bottom up, trying to touch eac | — |
Secondary
| Measure | Time frame |
|---|---|
| Participants are evaluated at the beginning (baseline), at the end of the 10 weeks of intervention (post-intervention) and 6 months after the end of the intervention (follow-up). 1. Weight in kg measured with an electronic balance with a sensitivity of 0.1 kg (Tanita BC 418 MA) 2. Height in cm measured with square and measuring tape of 0.1 cm precision 3. Body mass index (BMI) is obtained using the formula: Body weight (kg)/height in m squared 4. Body fat mass calculated using the Durnin and Womersley method from measurements of skin-fold thickness taken using a 0.5 mm sensitivity Slim Guide caliper 5. Muscle mass calculated using Lee's method from limb girth measurements corrected for skin-fold thicknesses 6. Body fat percentage calculated using the Siri method from the body fat mass and muscle mass 7. Visceral fat measured using a Tanita BC-418 multifrequency and segmental bioimpedance device 8. Lean mass measured using a Tanita BC-418 multifrequency and segmental bioimpedance device 9. Body composition measured using a Tanita BC-418 multifrequency and segmental bioimpedance device at the same time of day to avoid errors due to differences in hydration. 8 electrodes located on feet and hands are used. The participants are placed in standing position and perform a flexion of the scapulo-humeral joint of approximately 30º. 10. Exercise-induced muscle damage assessed using creatine kinase level in blood 11. Presence of metabolic syndrome assessed using cholesterol and triglyceride levels in blood 12. Presence of diabetes mellitus and cardiovascular risk assessed by measuring glucose level in blood 13. Osmotic balance assessed by measuring blood sodium and potassium levels 14. Thyroid function assessed using Thyroid Stimulating Hormone (TSH) in b | — |
Countries
Spain
Contacts
Public ContactAlvaro De Pano Rodríguez
Outcome results
None listed